Applikon Biotechnology in breakthrough for bioprocessing market
Dutch company Applikon Biotechnology, a leading manufacturer and supplier of bioreactor systems, has launched what it says is a breakthrough for the bioprocessing market.
Dutch company Applikon Biotechnology, a leading manufacturer and supplier of bioreactor systems, has launched what it says is a breakthrough for the bioprocessing market.
i-ControlXL is an easy-to-use platform specifically designed for the bio-process industry that offers industrial power, reliability and expandability using standard controllers (PLC) and distributed control systems (DCS).
It is said to offer enjoy a number of benefits to the scientific and engineering communities, including intuitive navigation; a colour touch screen interface; options for bioreactor controls, pumps and sensors; the ability to use the same system to control autoclavable vessels, single-use bioreactors or SIP/CIP systems; and impressively sufficient expandability to meet future needs.
'Bioprocess-related issues, such as high-throughput screening, scaling up, scaling down and PAT, are no longer a trend but a 'must' in this arena,' said Applikon Biotechnology's Hans van den Berg. 'A Manufacturing Execution Systems (MES) involves managing engineering changes and tracing material for regulatory compliance, conforming to increasingly stringent quality standards, delivering on schedule despite shrinking lead times, and reducing costs. Our i-ControlXL platform addresses these issues.'